Cite
MLA Citation
Kevin Kalinsky et al.. “A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG‐ACRIN Cancer Research Group (E2607).” Cancer, vol. 123, no. 14, 2017, pp. 2688–2697. http://access.bl.uk/ark:/81055/vdc_100047422074.0x00005f